Promoter group firms amalgamated into Castilia Life Sciences
HIKAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Two promoter group entities - Shri Rameshwara Investment and Shri Badrinath Investment - have merged into Castilia Life Sciences, also a promoter group firm. The composite scheme was approved by the Regional Director (Western Region, Mumbai) on November 18, 2025 and made effective on December 3, 2025. Consequently, the Hikal shares held by the two merged entities have now vested with Castilia.
Internal promoter group consolidation only. No change in public shareholding, business, or operations. Neutral for minority shareholders.